
Further investigations are needed to support its usage, particularly the validation of the tool with other standardized developmental diagnostic tools. Due to a fair to moderate agreement but low sensitivity between the ASQ-3 Thai and DDST-II, other validated tools should accompany the clinical usage of the tool. Specificity of the tool when compared to the DDST-II were 78.6%, 71.4% and 90.9%, respectively.Ĭonclusion: This was a preliminary study of the ASQ-3 Thai version for developmental screening in clinical setting. Results: A fair to moderate agreement (Kappa agreement = 0.338-0.606) was found between the ASQ-3 Thai and the DDSTII. Sensitivity of the ASQ-3 Thai with DDST-II at the age of 18, 24, and 30 months were 66.7%, 88.2%, and 54.5%, respectively.

Kappa analysis was used to calculate agreement between the ASQ-3 Thai and DDST-II. Concurrent validity of the ASQ-3 Thai with DDST-II was determined by descriptive statistics using the cross tabulation technique. Parents of the enrolled children simultaneously completed their toddler’s age-specific version of the ASQ-3 Thai questionnaire. Denver II Test Form PDF Original Title: Denver II Test Form. Participants were developmentally assessed by the DDST-II performed by a developmental pediatrician (BS). Each age group included 15 normal and 15 suspected cases. TheDenverDevelopmentalScreeningTest (DDST)was devisedtoprovide asimplemethodofscreeningforevidences ofslow developmentininfants andpreschoolchildren.Thetest covers fourfunctions:grossmotor, language, finemotor-adaptive,andpersonal-social.Ithas been standardizedon1,036presumablynormalchildren(twoweeks tosix years ofage) whose families refle. Material and Method: Children at the ages of 18, 24, and 30 months were enrolled. Objective: To determine the concurrent validity of the Ages & Stages Questionnaires, Third Edition, Thai-version (ASQ-3 Thai) with the Denver Developmental Screening Test II (DDST-II) and agreement between them in developmental status screening in toddlers.
